Drug Candidate Successfully Treats Atherosclerosis, Fatty Liver Disease in Large Mammals

April 22, 2025
Read time: <5 mins
V2blood Cells

A new drug developed at the University of Michigan is showing promise in treating two serious conditions: clogged arteries (atherosclerosis) and severe fatty liver disease. Early results in primates suggest it could help prevent these problems before they start. Read on to discover what makes this treatment different—and why researchers are so hopeful about its future.

Share:
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.